RI-MUHC researchers awarded CIHR funding for high-impact programs

15 of its members have been awarded inaugural Foundation grants by the CIHR

The Research Institute of the McGill University Health Centre (RI-MUHC) is proud to announce that 15 of its members have been awarded inaugural Foundation grants for high-impact, long-term programs in the latest round of funding by the Canadian Institutes of Health Research (CIHR).

The grants, which will support research at the RI-MUHC in areas from brain disorders to treatments of latent Tuberculosis, are part of over $600 million in funding announced today by Health Minister Rona Ambrose for researchers working at universities and hospitals across Canada.

The announcement covers two categories of funding:

  • A new category, called “Foundation” grants (highlighted below) provides larger amounts of long-term support for innovative, high-impact programs of research. A total of 24 researchers from McGill University and its hospital affiliated research institutes, including the RI-MUHC, have been awarded these grants for a total of $60.6 million.
  • Transitional Open Operating grants, for specific projects, provide a total of more than $30 million for 44 McGill researchers.

The Foundation grants cover a seven-year period for established investigators, and five years for early-career investigators.

Below is a lit of the RI affiliated recipients of Foundation grants, indicating the institution and/or Faculty of the investigator; a description of the program; and the amount of the award. (* indicates early-career investigator):

  • Bourque, Charles W , Research Institute of the McGill University Health Centre, Medicine. Central control of osmoregulation in health and disease. $2,719,408 
  • Dagher, Alain, Medicine. Functional Neuroimaging of dopamine systems: application to Parkinson's Disease, addiction and obesity. $2,155,301
  • Divangahi, Maziar *, Research Institute of the McGill University Health Centre, Medicine. Regulation of Anti-Microbial Macrophage Response to Pulmonary Infections. $1,293,210 
  • Gotman, Jean, Medicine. Electrical and metabolic manifestations of human focal epilepsy. $2,291,930
  • Klein, Marina B ,  Research Institute of the McGill University Health Centre, Medicine. Tracking a revolution: Evaluating the impact of modern HCV therapy on HIV-HCV coinfection. $4,835,202
  • Menzies, Richard , Research Institute of the McGill University Health Centre, Medicine. Tackling the two greatest obstacles to Tuberculosis elimination: Treatment of latent infection and drug resistant disease.  $7,899,734 
  • Park, Morag, Medicine. Mechanisms of Met activation in cancer and therapeutic intervention. $3,507,282 
  • Petrides, Michael, Medicine. Comparative functional and anatomical study of human and monkey cortex. $1,665,281
  • Platt, Robert W,  Research Institute of the McGill University Health Centre, Medicine. Statistical Methods in Pharmacoepidemiology and Perinatal Epidemiology. $1,071,717 
  • Rak, Janusz, Research Institute of the McGill University Health Centre, Medicine. Targeting vascular mechanisms of cancer progression. $3,313,788 
  • Rouleau, Guy A, Medicine. Genetic & Biological Studies of Brain Disorders. $4,959,666
  • Ruthazer, Edward S , Medicine. Cellular and molecular mechanisms underlying activity-dependent neural circuit development. $2,184,958 
  • Schurr, Erwin A  , Research Institute of the McGill University Health Centre, Medicine. Host genetic dissection of mycobacterial infection phenotypes.  $2,478,941
  • Seuntjens, Jan P  , Research Institute of the McGill University Health Centre, Medicine. Monte Carlo techniques in the optimization of radiation therapy delivery and outcomes. $596,694 
  • Zatorre, Robert J , Medicine. Auditory Cognitive Neuroscience: Pathways, Processes, Plasticity and Predispositions. $1,889,652 


A full list of CIHR grant recipients is available here: http://www.cihr-irsc.gc.ca/e/196.html